SANUWAVE Health, Inc. (SNWV) Q3 2025 Earnings Call Transcript

Operator
Good day, everyone, and welcome to the SANUWAVE Q3 Revenue Update. [Operator Instructions] Please note today’s call will be recorded. [Operator Instructions]
It is now my pleasure to turn today’s conference over to Morgan Frank, CEO.
Morgan Frank
CEO & Chairman
Thank you very much. Welcome to SANUWAVE’s Third Quarter 2025 Revenue Pre-announcement Call. Our press release on this went out earlier this afternoon. Joining me on the call is Peter Sorensen, our CFO. And after the presentation, we will open the call up to Q&A.
So we’ll begin with the always riveting forward-looking statements and other disclosures. This call may contain forward-looking statements such as statements relating to future financial results, production expectations and plans for future business development activities. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control.
A description of these risks, uncertainties and other factors that could affect our financial results is included in our SEC filings. Actual results may differ materially from those projected in the forward-looking statements. The company undertakes no obligation to update any forward-looking statement. Certain percentages in this call are calculated from the underlying whole dollar amounts and therefore, may not recalculate some rounded numbers used for disclosure purposes.
As best preface, let’s get to it. As you’ve likely seen, the company preannounced Q3 2025 revenues today after market close. We came in at $11.4 million to $11.6 million, an all-time quarterly record for the company, representing 12% to 14% sequential growth from Q2 and 22% to